Packaging demand rises; Generics recall in U.K.;

> World pharmaceutical packaging demand is projected to increase 6.3 percent annually to $62.3 billion in 2013. Article

> Eight pharma companies were forced to recall generics in the U.K. last week after regulators found "serious" deficiencies in manufacturing practices at a single contract manufacturer in India. Report

> Abbott Laboratories has named Olivier Bohuon executive vice president for pharmaceutical products. Bohuon succeeds James Tyree, who will move to a new role as president of Abbott Biotech Ventures Inc., a unit that invests in early-stage pharmaceuticals and biologics. Announcement

> Some 350 Caraco Pharmaceutical workers will bear the brunt of a much-publicized production stoppage following the FDA seizure of 33 medications and drug ingredients. Report

> Xianyang, China-based Biostar Pharmaceuticals, a manufacturer of pharmaceutical products and medical nutrients, has begun implementation of a rural cooperative drug supply network plan. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.